Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
04/2014
04/10/2014WO2014055397A1 Tablet containing composite with cyclodextrin
04/10/2014WO2014055338A1 Decubitus treatment system
04/10/2014WO2014055055A1 Pharmaceutical composition of 1-adamantylethyloxy-3-morpholino-2-propanol or pharmaceutically acceptable salts thereof for the treatment of cerebrovascular disease and neurodegenerative diseases of the central nervous system
04/10/2014WO2014055053A1 Pharmaceutical composition of 1-adamantylethyloxy-3-morpholino-2-propanol or pharmaceutically acceptable salts thereof for the treatment of cardiovascular disease
04/10/2014WO2014055047A1 Combination of idebenone and donezepil
04/10/2014WO2014054970A1 Solid dosage form having an anorectic effect (variants)
04/10/2014WO2014054969A1 Solid dosage form having a choleretic effect (variants)
04/10/2014WO2014054965A1 Combination for the prophylaxis and treatment of behavioural, mental and cognitive disorders
04/10/2014WO2014054880A1 Novel laxative composition with improved stability, containing polyethylene glycol and vitamin c
04/10/2014WO2014054702A1 Hydrogel-forming material, premix, and hydrogel formation method
04/10/2014WO2014054699A1 Hydrogel-forming material
04/10/2014WO2014054588A1 Nanogel/exosome complex and dds
04/10/2014WO2014054026A1 Liposomal drug delivery system
04/10/2014WO2014053974A1 Pharmaceutical compositions of sirolimus
04/10/2014WO2014053822A1 Layered double hydroxides
04/10/2014WO2014053790A1 Process for granulation of 1,4:3,6-dianhydrohexitols, granules obtained and uses thereof
04/10/2014WO2014053592A1 Esters of short chains fatty acids for use in the treatment of immunogenic disorders
04/10/2014WO2014053571A1 Virus-containing formulation and use thereof
04/10/2014WO2014053555A1 Veterinary drug system
04/10/2014WO2014053542A1 Drug delivery composition comprising proteins and biodegradable polyesteramides
04/10/2014WO2014053482A1 Methods and pharmaceutical compositions for the prophylactic treatment of bacterial superinfections post-influenza with invariant nkt cell agonists
04/10/2014WO2014053370A1 Edible foam comprising a drug
04/10/2014WO2014053352A1 Ingestible capsule for remote controlled release of a substance
04/10/2014WO2014053328A2 Pharmaceutical compositions
04/10/2014WO2014053263A1 Pharmaceutical composition for the treatment of hoarseness or sore throat
04/10/2014WO2014053262A1 Composition, in particular a pharmaceutical composition, in particular for administration in hoarseness
04/10/2014WO2014053081A1 Design and manufacture of nonelectronic, active-infusion patch and device for transdermal delivery across skin
04/10/2014WO2014027982A3 Novel effervescent sachet formulations of dapoxetine and a pde5 inhibitor
04/10/2014WO2014027965A8 Wound dressing nanomesh impregnated with human umbilical cord wharton's jelly stem cells
04/10/2014WO2014027334A3 Oral pharmaceutical composition in the form of microspheres and preparation method
04/10/2014WO2013188016A3 Surfactant therapy for exposure to ionizing radiation
04/10/2014US20140100537 Transdermal pharmaceutical preparation and administration of tirofiban
04/10/2014US20140100285 Compositions of percutaneous administration of physiologically active agents
04/10/2014US20140100283 Method to Increase Absorption and Bioavailability of Oral Glutathione
04/10/2014US20140100256 Formulations of enzalutamide
04/10/2014US20140100185 Unit dosage of apadenoson
04/10/2014US20140100183 Central administration of stable formulations of therapeutic agents for cns conditions
04/10/2014US20140100182 Nanogel-Mediated Drug Delivery
04/10/2014US20140099696 Technology for the Preparation of Microparticles
04/10/2014US20140099426 Natural coating formulas and composition for coating tablets
04/10/2014US20140099382 Treatment using dantrolene
04/10/2014US20140099380 Microparticle Formulations for Delivery to the Lower and Central Respiratory Tract and Methods of Manufacture
04/10/2014US20140099379 Bio-compatible nano and microparticles coated with stabilizers for pulmonary application
04/10/2014US20140099378 Modified Release Formulations of Anti-Irritability Drugs
04/10/2014US20140099377 Continuous method for producing nanoparticles and nanoparticles obtained by means of said method
04/10/2014US20140099376 Sequestered antagonist formulations
04/10/2014US20140099375 Methods of therapeutic treatment of eyes
04/10/2014US20140099372 Crystalline microspheres and the process of manufacturing the same
04/10/2014US20140099371 Medicinal carriers, and preparation method and uses thereof
04/10/2014US20140099369 Tamper-resistant oral opioid agonist formulations
04/10/2014US20140099368 Dosage forms of active ingredients containing hydroxystilbene for treating menopausal complaints
04/10/2014US20140099365 Novel pharmaceutical composition
04/10/2014US20140099364 Controlled release pharmaceutical compositions comprising a fumaric acid ester
04/10/2014US20140099363 Capsules comprising an emulsified syrup and methods of making the same
04/10/2014US20140099361 Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
04/10/2014US20140099360 Gas Storage Vessel, Hydrogen-Charging Method, and Hydrogen-Charging Apparatus
04/10/2014US20140099359 Synthetic platelets
04/10/2014US20140099358 Vaccines with enhanced immune response and methods for their preparation
04/10/2014US20140099357 Biologically Efficacious Compositions, Articles of Manufacture and Processes for Producing and/or Using Same
04/10/2014US20140099351 Process for making controlled release medical implant products
04/10/2014US20140099344 Process for dispersing amino acids
04/10/2014US20140099343 Ophthalmic Device, and Method of Use Thereof, for Increasing Ocular Boundary Lubrication
04/10/2014US20140099342 Botulinum nanoemulsions
04/10/2014US20140099269 Chewing gum having sustained release of nicotine
04/10/2014US20140097114 Liquid pharmaceutical formulations of palonosetron
04/09/2014EP2716637A1 Mangiferin aglycone crystal form i and preparation method thereof
04/09/2014EP2716304A1 LIPOSOME CONTAINING shRNA MOLECULE FOR THYMIDYLATE SYNTHASE, AND USE FOR SAME
04/09/2014EP2716290A1 Dry-coated tablet containing tegafur, gimeracil and oteracil potassium
04/09/2014EP2716289A1 Wound and mucous membrane antiseptic based on Bispyridiniumalkanes
04/09/2014EP2716288A1 A method for decreasing symptoms of alcohol consumption
04/09/2014EP2716287A1 Ropinirole-containing adhesive skin patch and packaged product thereof
04/09/2014EP2716286A1 Ropinirole-containing adhesive patch and packaging therefor
04/09/2014EP2716284A2 Polyethylene oxide-based films and drug delivery systems made herefrom
04/09/2014EP2716283A1 Gastric reflux resistant dosage forms
04/09/2014EP2716282A1 Controlled release pharmaceutical composition
04/09/2014EP2716281A1 Method for producing powder for inhalation
04/09/2014EP2716280A1 Method for obtaining plasma membrane vesicles extracted from plants enriched in membrane transport proteins, and uses thereof
04/09/2014EP2716279A1 Oral solutions containing leukotriene antagonists
04/09/2014EP2714888A2 Recombinant yeast
04/09/2014EP2714777A1 Polysaccharide-based hydrogel polymer and uses thereof
04/09/2014EP2714716A1 Matriptase inhibitors and uses thereof against orthomyxoviridae infections
04/09/2014EP2714162A2 Inhalator and capsule for an inhalator
04/09/2014EP2714117A1 Systems and methods of stimulation and activation of fluids for use with instillation therapy
04/09/2014EP2714090A1 Brain tumor targeting peptides and methods
04/09/2014EP2714088A1 Mucosal delivery of drugs
04/09/2014EP2714044A1 Composition and tablet comprising raltegravir
04/09/2014EP2714021A1 Composition of monoterpenoids having bactericidal properties
04/09/2014EP2714019A1 Compositions for percutaneous administration of physiologically active agents
04/09/2014EP2714018A1 Transdermal therapeutic system comprising buprenorphine and an alpha-hydroxy acid
04/09/2014EP2714017A2 Membrane encapsulated nanoparticles and method of use
04/09/2014EP2714016A1 Targeted delivery of retinoid compounds to the sebaceous glands
04/09/2014EP2714015A1 Controlled release solid dose forms
04/09/2014EP2714014A2 Encapsulated polar materials and methods of preparation
04/09/2014EP2714013A1 Powdery mixture for producing tablets containing levetiracetam
04/09/2014EP2714012A1 Cb-183,315 compositions and related methods
04/09/2014EP2714011A2 Liposomal mitigation of drug-induced long qt syndrome and potassium delayed-rectifier current
04/09/2014EP2714010A2 Topical pharmaceutical composition based on semifluorinated alkanes
04/09/2014EP2714009A1 Stable liquid formulation of etanercept
04/09/2014EP2714008A2 Pharmaceutical composition for administration to nails
04/09/2014EP2714007A2 Ophthalmic preparation comprising a pgf2alpha analogue
1 ... 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 ... 2991